Study directory

Mental health studies with practical context.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.

Back to overview
3187studies shown
Showing 151-175 of 3,187
Not Yet RecruitingNCT06689787

A Mobile Health Intervention to Improve Psychosocial Functioning in Veterans With Posttraumatic Stress Disorder and Depression Symptoms

This study is looking at whether a digital support tool can help people with Psychosocial Functioning, Stress Disorders, Post-Traumatic, or major depression. Participants take part in the therapy or support program and complete follow-up questionnaires or assessments.

DepressionOtherOver 18 Years
Countries
United States
Sponsor
VA Office of Research and Development
Condition
Depression
Active Not RecruitingNCT04201106

A Neuroimaging Study of Open-label Placebo in Depressed Adolescents

This study is comparing Open Label Placebo with Rationale with placebo for people with Depression. Participants receive Open Label Placebo with Rationale or placebo and complete study visits and assessments.

DepressionBehavioralFrom 13 Years to 18 Years
Countries
United States
Sponsor
University of California, San Francisco
Condition
Depression
RecruitingNCT06188923

A New Intervention to Improve Function in Veterans With Anxiety and Depression

This observational study is following people with Anxiety and Depression to understand outcomes over time. Participants are followed over time so researchers can learn from clinical and follow-up information.

DepressionOtherFrom 18 Years to 65 Years
Countries
United States
Sponsor
VA Office of Research and Development
Condition
Depression
Active Not RecruitingNCT06941844

A Phase 3 Trial of MM120 for Major Depressive Disorder (Emerge)

This study is comparing Placebo with placebo for people with depression. Participants receive Placebo or placebo and complete study visits and assessments.

DepressionOtherFrom 18 Years to 74 Years
Countries
United States
Sponsor
Definium Therapeutics US, Inc.
Condition
Depression
Not Yet RecruitingNCT03833206

A Phase I/II Study of PDC-1421 for Treating Depression in Cancer Patients

This study is looking at evaluate the safety and the effective doses of PDC-1421 in cancer patients with depression. Participants receive a study treatment and complete follow-up visits and assessments.

DepressionOtherFrom 21 Years to 85 Years
Countries
United States
Sponsor
BioLite, Inc.
Condition
Depression
Active Not RecruitingNCT05733546

A Phase II, Multicentre, Randomised, Double-blind, Controlled Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Efficacy of COMP360 in Participants With Recurrent Major Depressive Disorder

This observational study is following people with depression to understand outcomes over time. Participants are followed over time so researchers can learn from clinical and follow-up information.

DepressionDrugOver 18 Years
Countries
United States
Sponsor
COMPASS Pathways
Condition
Depression
RecruitingNCT03887715

A Prospective, Multi-center, Randomized Controlled Blinded Trial Demonstrating the Safety and Effectiveness of VNS Therapy® System as Adjunctive Therapy Versus a No Stimulation Control in Subjects With Treatment-Resistant Depression

This study is looking at whether a digital support tool can help people with Treatment Resistant Depression. Participants take part in a digital support tool and complete follow-up assessments.

DepressionOtherOver 18 Years
Countries
United States
Sponsor
LivaNova
Condition
Depression
RecruitingNCT06906939

A Randomized Pilot rTMS Trial for Knee Arthritis Pain and Depression

This study is looking at whether a digital support tool can help people with Knee Osteoarthritis or Depression. Participants take part in a digital support tool and complete follow-up assessments.

DepressionOtherFrom 50 Years to 95 Years
Countries
United States
Sponsor
University of California, Los Angeles
Condition
Depression
CompletedNCT05841030

A Study in Participants With Major Depressive Disorder (MDD) With Anhedonia and Inadequate Response to Current Antidepressant Therapy Including a Selective Serotonin Reuptake Inhibitor (SSRI) or Serotonin Norepinephrine Reuptake Inhibitor (SNRI)

This observational study is following people with major depression to understand outcomes over time. Participants are followed over time so researchers can learn from clinical and follow-up information.

DepressionOtherFrom 18 Years to 74 Years
Countries
Argentina, Brazil, Canada, France, Germany, Italy, South Korea, Spain, Sweden, United Kingdom, United States
Sponsor
Janssen Research & Development, LLC
Condition
Depression
Active Not RecruitingNCT03642964

A Study in Patients With Major Depressive Disorder

This study is comparing CTC-501 with placebo for people with depression. Participants receive CTC-501 or placebo and complete study visits and assessments.

DepressionDrugFrom 18 Years to 65 Years
Countries
United States
Sponsor
Chase Therapeutics Corporation
Condition
Depression
TerminatedNCT05518149

A Study of Aticaprant in Adult and Elderly Participants With Major Depressive Disorder (MDD)

This study is looking at whether Aticaprant can help people with major depression. Participants take part in Aticaprant and complete follow-up assessments.

DepressionOtherFrom 18 Years to 74 Years
Countries
Argentina, Australia, Belgium, Brazil, Bulgaria, Canada, China, Czech Republic, France, Hungary, Italy, Poland, Portugal, Slovakia, South Africa, South Korea, Spain, Sweden, Taiwan, United Kingdom, United States
Sponsor
Janssen Research & Development, LLC
Condition
Depression
RecruitingNCT07412756

A Study of Brenipatide in Adult Participants With Major Depressive Disorder

This study is comparing Brenipatide with placebo for people with major depression. Participants receive Brenipatide or placebo and complete study visits and assessments.

DepressionOtherFrom 18 Years to 75 Years
Countries
Australia, Brazil, Canada, China, Germany, Greece, Japan, Mexico, Poland, United States, South Korea, Spain, Taiwan, United Kingdom
Sponsor
Eli Lilly and Company
Condition
Depression
RecruitingNCT06793397

A Study of a Deuterated Psilocin Analog (CYB003) in Humans With Major Depressive Disorder

This study is testing whether CYB003, compared with placebo, is safe and helpful as an add-on treatment for people with depression. Participants receive CYB003 or placebo and complete study visits and assessments.

DepressionOtherFrom 18 Years to 85 Years
Countries
Australia, Czech Republic, Germany, Greece, Ireland, Poland, United Kingdom, United States
Sponsor
Cybin IRL Limited
Condition
Depression
RecruitingNCT07186309

A Study of a Test for Postpartum Depression at Home

This observational study is following people with Postpartum Depression or Pregnancy to understand outcomes over time. Participants mainly provide questionnaire, assessment, or follow-up information rather than receiving a new study treatment.

DepressionDeviceOver 18 Years
Countries
United States
Sponsor
University of Virginia
Condition
Depression